# Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

> **NCT02298985** · PHASE4 · COMPLETED · sponsor: **Beersheva Mental Health Center** · enrollment: 38 (actual)

## Conditions studied

- Chronic Schizophrenia

## Interventions

- **DRUG:** Curcumin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02298985
- **Lead sponsor:** Beersheva Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02298985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02298985, "Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02298985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*